Bank of Montreal’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-432
Closed -$2K 5564
2021
Q1
$2K Sell
432
-4,790
-92% -$26.4K ﹤0.01% 4955
2020
Q4
$21K Buy
5,222
+1,890
+57% +$8.08K ﹤0.01% 4412
2020
Q3
$13K Sell
3,332
-571
-15% -$2.37K ﹤0.01% 4051
2020
Q2
$17K Buy
3,903
+1,403
+56% +$8.54K ﹤0.01% 3937
2020
Q1
$13K Sell
2,500
-5,433
-68% -$34.3K ﹤0.01% 3412
2019
Q4
$31K Buy
7,933
+830
+12% +$4.9K ﹤0.01% 4076
2019
Q3
$63K Buy
7,103
+60
+0.9% +$567 ﹤0.01% 3517
2019
Q2
$65K Buy
7,043
+1,506
+27% +$11.3K ﹤0.01% 3572
2019
Q1
$36K Buy
5,537
+4,984
+901% +$32.5K ﹤0.01% 3478
2018
Q4
$5K Buy
553
+405
+274% +$6.09K ﹤0.01% 4137
2018
Q3
$3K Sell
148
-4
-3% -$105 ﹤0.01% 4305
2018
Q2
$4K Buy
+152
New +$4.69K ﹤0.01% 4227
2017
Q4
Sell
-10,899
Closed -$379K 4519
2017
Q3
$379K Buy
10,899
+10,799
+10,799% +$347K ﹤0.01% 2397
2017
Q2
$3K Sell
100
-3,000
-97% -$86K ﹤0.01% 4006
2017
Q1
$93K Buy
+3,100
New +$79.1K ﹤0.01% 2855
2014
Q3
Sell
-12,000
Closed -$110K 4987
2014
Q2
$110K Buy
12,000
+2,000
+20% +$18.3K ﹤0.01% 2791
2014
Q1
$108K Buy
+10,000
New +$98.1K ﹤0.01% 2769

Other funds holding LJPC

Bank of Montreal's LJPC Position: Q2 2021 in Review

Bank of Montreal sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 432 shares — an estimated $2K sold.

Bank of Montreal first reported a position in LJPC in Q1 2014 and held it in 17 quarters. The position peaked at $379K in Q3 2017. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Bank of Montreal reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 432 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 17 quarters.
  • Bank of Montreal's La Jolla Pharmaceutical Company position peaked at $379K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.